文献速递病毒性肝炎

IL-12而非免疫检查点抑制剂助力HDV特异性T细胞功能恢复

The Third Signal Cytokine Interleukin 12 Rather Than Immune Checkpoint Inhibitors Contributes to the Functional Restoration of Hepatitis D Virus-Specific T Cells.
PubMed 文献 · J Infect Dis · 2016-10-31

该研究在49例HDV感染者、25例HBV单感染者和18例健康对照中分析免疫细胞频率与表型,并用重叠肽段刺激评估T细胞增殖与细胞因子产生能力。结果显示HDV特异性T细胞反应微弱,阻断PD-1通路仅部分恢复,而添加IL-12可更稳健且一致地增强HDV特异性CD4+和CD8+ T细胞反应。

要点

  • HDV感染者CD8+ T细胞中衰老标志物CD57显著上调。
  • 阻断PD-1通路仅部分恢复HDV特异性T细胞反应。
  • 添加IL-12可更稳健增强HDV特异性CD4+和CD8+ T细胞反应。

核心结论

  • HDV感染患者存在免疫细胞早衰和T细胞功能受损,补充IL-12而非仅阻断抑制性通路可更有效恢复HDV特异性T细胞功能。

研究设计与样本

  • 研究纳入49例HDV感染者、25例HBV单感染者和18例健康对照,检测免疫细胞频率与表型。
  • 用覆盖大HDV抗原的重叠肽段刺激分析T细胞增殖和细胞因子产生能力。
  • 使用抗CTLA-4、抗PD-L1阻断抗体或促炎细胞因子IL-12以恢复T细胞反应。

主要发现

  • 各组间免疫细胞频率和表型无差异,仅HDV感染者CD8+ T细胞中CD57显著上调。
  • HDV特异性T细胞增殖和细胞因子产生微弱,阻断PD-1通路仅部分挽救。
  • 添加IL-12后HDV特异性CD4+和CD8+ T细胞反应更稳健且一致地增加,并影响CMV和EBV特异性T细胞。

临床怎么用

  • HDV感染者T细胞功能受损,评估免疫衰老标志物如CD57可能有助于识别免疫功能障碍。
  • IL-12补充或为恢复HDV特异性T细胞功能的潜在免疫干预策略,但需进一步临床验证。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hepatitis D virus (HDV) infection affects 15-20 million individuals worldwide and causes severely progressive hepatitis. It is unknown to what extent cellular immune responses contribute to liver disease and control of viral replication in HDV infection. METHODS: Immune cell frequencies and phenotypes were determined in 49 HDV-infected patients, 25 individuals with hepatitis B virus monoinfection and 18 healthy controls. T-cell proliferative and cytokine-producing capacities were analyzed by stimulation with overlapping peptides spanning the large HDV antigen. To restore T-cell responses, blocking antibodies (anti-cytotoxic T-lymphocyte antigen 4, anti-programmed death ligand 1) or proinflammatory cytokines (interleukin [IL] 12) were used. RESULTS: Immune cell frequencies and phenotypes did not vary between the groups. Exclusively, the senescence marker CD57 was significantly up-regulated in CD8+ T cells from patients with hepatitis delta. HDV-specific T-cell proliferation and cytokine production were weak and could only partly be rescued by blockade of the programmed death 1 pathway. However, a more robust and consistent increase in HDV-specific CD4+ and CD8+ T-cell responses was evident when the third signal cytokine IL-12 was added, which also affected cytomegalovirus- and Epstein-Barr virus-specific T cells. CONCLUSIONS: This investigation of virus-specific T-cell immunity in patients with HDV infection, the largest to date, revealed premature aging of immune cells and impaired T-cell functionality. This could be restored by blocking inhibitory pathways and, in particular, by supplementing with IL-12.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Schirdewahn T, Grabowski J, Owusu Sekyere S, et al. The Third Signal Cytokine Interleukin 12 Rather Than Immune Checkpoint Inhibitors Contributes to the Functional Restoration of Hepatitis D Virus-Specific T Cells. J Infect Dis. 2016. PMID: 27803174. doi:10.1093/infdis/jiw514

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。